Indegene simplified complex hematologic cancer forecasting for a global pharma company focused on cardiovascular, metabolism, immunology, and oncology therapeutics that predict and preempt diseases. Challenges included time-intensive model building that diverted focus from scenario analysis. Indegene's NEXT Forecasting software enabled users to efficiently construct forecast models with minimal time investment, eliminating hours spent on formula validation. This empowered rapid scenario testing and strategic evaluation, allowing teams to prioritize high-value analysis over tedious manual processes for superior forecasting accuracy and decision-making.

Join for free to read